These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 2961943

  • 1. Alpha-h-ANP injection in normals, low renin hypertension and primary aldosteronism.
    Mantero F, Rocco S, Pertile F, Carpené G, Fallo F, Menegus A.
    J Steroid Biochem; 1987; 27(4-6):935-40. PubMed ID: 2961943
    [Abstract] [Full Text] [Related]

  • 2. Effect of alpha-human atrial natriuretic peptide in low renin essential hypertension and primary aldosteronism.
    Mantero F, Rocco S, Pertile F, Carpenè G, Fallo F, Leone L, Boscaro M.
    Clin Exp Hypertens A; 1987; 9(10):1505-13. PubMed ID: 2960475
    [Abstract] [Full Text] [Related]

  • 3. Atrial natriuretic peptide infusion in primary aldosteronism. Renal, hemodynamic and hormonal effects.
    Rocco S, Opocher G, Carpenè G, Mantero F.
    Am J Hypertens; 1990 Sep; 3(9):668-73. PubMed ID: 2145872
    [Abstract] [Full Text] [Related]

  • 4. Circadian rhythms of atrial natriuretic peptide, renin, aldosterone, cortisol, blood pressure and heart rate in normal and hypertensive subjects.
    Portaluppi F, Bagni B, degli Uberti E, Montanari L, Cavallini R, Trasforini G, Margutti A, Ferlini M, Zanella M, Parti M.
    J Hypertens; 1990 Jan; 8(1):85-95. PubMed ID: 2157761
    [Abstract] [Full Text] [Related]

  • 5. [The significance of atrial natriuretic polypeptide in the cause of essential hypertension].
    Mori K.
    Nihon Naibunpi Gakkai Zasshi; 1991 Jul 20; 67(7):796-810. PubMed ID: 1653713
    [Abstract] [Full Text] [Related]

  • 6. Low calorie diet enhances renal, hemodynamic, and humoral effects of exogenous atrial natriuretic peptide in obese hypertensives.
    Dessì-Fulgheri P, Sarzani R, Serenelli M, Tamburrini P, Spagnolo D, Giantomassi L, Espinosa E, Rappelli A.
    Hypertension; 1999 Feb 20; 33(2):658-62. PubMed ID: 10024323
    [Abstract] [Full Text] [Related]

  • 7. Hormonal and renal effects of atrial natriuretic peptide in patients with secondary hypertension.
    Hirata Y, Ishii M, Sugimoto T, Matsuoka H, Fukui K, Sugimoto T, Yamakado M, Tagawa H, Miyata A, Kangawa K.
    Circulation; 1988 Dec 20; 78(6):1401-10. PubMed ID: 2847885
    [Abstract] [Full Text] [Related]

  • 8. Cardiovascular, renal and endocrine effects of alpha-human atrial natriuretic peptide in patients with Cushing's syndrome and primary aldosteronism.
    Fujio N, Ohashi M, Nawata H, Kato K, Matsuo H, Ibayashi H.
    J Hypertens; 1989 Aug 20; 7(8):653-9. PubMed ID: 2553806
    [Abstract] [Full Text] [Related]

  • 9. Role of atrial natriuretic peptide in mineralocorticoid escape phenomenon in patients with primary aldosteronism.
    Nakamura T, Ichikawa S, Sakamaki T, Sato K, Kogure M, Tajima Y, Kato T, Murata K.
    Proc Soc Exp Biol Med; 1987 Sep 20; 185(4):448-54. PubMed ID: 2956609
    [Abstract] [Full Text] [Related]

  • 10. Effect of atrial natriuretic peptide (8-33-Met ANP) in patients with hypertension.
    Franco-Saenz R, Somani P, Mulrow PJ.
    Am J Hypertens; 1992 May 20; 5(5 Pt 1):266-75. PubMed ID: 1533767
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hormonal responses to synthetic atrial natriuretic peptide in patients on regular hemodialysis.
    Nakajima S, Suzuki H, Kageyama Y, Takita T, Saruta T.
    Acta Endocrinol (Copenh); 1988 Oct 20; 119(2):257-62. PubMed ID: 2972150
    [Abstract] [Full Text] [Related]

  • 13. Atrial natriuretic peptide, renin and aldosterone in obstructive lung disease and heart failure.
    Carlone S, Palange P, Mannix ET, Salatto MP, Serra P, Weinberger MH, Aronoff GR, Cockerill EM, Manfredi F, Farber MO.
    Am J Med Sci; 1989 Oct 20; 298(4):243-8. PubMed ID: 2529764
    [Abstract] [Full Text] [Related]

  • 14. Prolonged decrease in blood pressure after atrial natriuretic peptide infusion in essential hypertension: a new anti-pressor mechanism?
    Singer DR, Markandu ND, Buckley MG, Miller MA, Sugden AL, Sagnella GA, MacGregor GA.
    Clin Sci (Lond); 1989 Sep 20; 77(3):253-8. PubMed ID: 2530019
    [Abstract] [Full Text] [Related]

  • 15. [Atrial natriuretic peptide (ANP) in essential hypertension: a humoral marker for salt sensitivity and hypertensive heart disease at a clinically asymptomatic stage?].
    Stimpel M, Kaufmann W, Wambach G.
    Z Kardiol; 1988 Sep 20; 77 Suppl 2():92-8. PubMed ID: 2970180
    [Abstract] [Full Text] [Related]

  • 16. Hormonal responses to gradual changes in dietary sodium intake in humans.
    Sagnella GA, Markandu ND, Buckley MG, Miller MA, Singer DR, MacGregor GA.
    Am J Physiol; 1989 Jun 20; 256(6 Pt 2):R1171-5. PubMed ID: 2525347
    [Abstract] [Full Text] [Related]

  • 17. Plasma atrial natriuretic peptide and its relation to the renin-angiotensin-aldosterone system in patients with chronic renal failure.
    Selçuk Y, San A, Bakan E, Yiğitoğlu R.
    Nephrol Dial Transplant; 1991 Jun 20; 6(8):557-61. PubMed ID: 1835523
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Renal and hormonal effects and tolerance of an ANP analogue in healthy man.
    Eiskjaer H, Schmiegelow M, Jespersen B, Tietze IN, Jensen JD, Sørensen SS, Thomsen K, Pedersen EB.
    Eur J Clin Pharmacol; 1991 Jun 20; 41(6):547-54. PubMed ID: 1840038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.